论文部分内容阅读
在人群中,有1%受到口腔扁平苔藓(LP)的侵袭。一些人以无症状白色损害形式存在,涉及或不涉及其他鳞状上皮;而另外一些人损害处疼痛,尤其在有萎缩、糜烂或存在剥脱性龈炎时更为如此。与皮肤LP不同,口腔LP易为慢性。并且,对于单独的口腔损害,难以找到可靠的姑息疗法。LP与其他口腔病(特别是盘状红斑狼疮和角化病)需进行活体组织检查才能鉴别。在排除任何已知致病因子(如某些药物)后,有症状的口腔LP通常采用可的松类激素(局部用或损害部位内注射)控制。氢化可的松、去炎松、醋酸肤轻松、倍他米松或强的松龙制剂都是有
In the population, 1% is affected by oral lichen planus (LP). Some people have asymptomatic white lesions, with or without other squamous epithelium, while others damage the pain, especially when there is shrinkage, erosion, or the presence of exfoliative gingivitis. Unlike skin LP, oral LP tends to be chronic. And, for individual oral lesions, it is difficult to find a reliable palliative treatment. LP and other oral diseases (especially discoid lupus erythematosus and keratosis) need to be biopsy in order to identify. After excluding any known causal agents (such as certain drugs), symptomatic oral LP is usually controlled with cortisone hormones (topical or intralesional injection). Hydrocortisone, triamcinolone, glaucescene acetate, betamethasone or prednisolone preparations are there